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Abstract Polymerisation of haematin to B-haematin (haemozoin or malaria pigment) in acidic acetate solutions was studied using infrared 
spectroscopy. The reaction was found to occur spontaneously between 6 and 65”C, in 0.1-4.5 M acetate and pH 4.2-5.0. The anti-malarial drugs 
quinine, chloroquine and amodiaquin were found to block spontaneous p-haematin formation, while the anti-malarially inactive 9-epiquinine and 
I-hydroxyquinoline had no effect on the reaction, as did primaquine, a drug which is active only against exo-erythrocytic stages of infection. It is 
argued that the intra-erythrocytically active anti-malarial agents act by binding to haematin, blocking j?-haematin formation and leaving toxic 
haematin in the parasite food vacuoles. 
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1. Introduction 
The high incidence of malaria, together with the appearance 
of drug-resistant strains of the organism, has rendered this 
disease a major human health problem [l]. The parasite infects 
host red blood cells, ingesting and degrading haemoglobin in 
acidic food vacuoles [2]. Released haem, which is toxic to the 
parasite [3], is converted into insoluble and inert malaria pig- 
ment (haemozoin) [4], a haem polymer referred to as /?-hae- 
matin [5]. The mode of action of quinoline anti-malarial drugs 
remains uncertain. It has been proposed that the drugs either 
raise the pH of the food vacuole [6], inhibiting haemoglobin 
proteolysis, alternatively that they bind to haem [7], killing the 
organism by toxic effects [S], or that they inhibit a putative 
haem polymerase nzyme, preventing haemozoin formation [9]. 
In the current study it is shown that spontaneous formation of 
/3-haematin is inhibited by the anti-malarial agents chloroquine, 
quinine and amodiaquin, but not by the therapeutically inactive 
substances 9-epiquinine and 8-hydroxyquinoline, nor by pri- 
maquine, a quinoline anti-malarial drug not active against the 
intra-erythrocytic stages of the parasite. This suggests that the 
mode of action of the intra-erythrocytically active anti-malari- 
als is to simply complex haem and prevent polymerization to 
/S-haematin. Based on these results, criteria for the rational 
design of these anti-malarial drugs can be envisaged. 
2. Materials and methods 
The formation ofg-haematin can be brought about non-biologically, 
i.e. in the absence of proteins, peptides etc., and it has been reported 
that product formation can be monitored by the differential solubilities 
*Corresponding author. 
In this work haem refers to iron protoporphyrin IX (often abbreviated 
as FPIX in the literature), haemin is ferriprotoporphyrin IX chloride, 
haematin is ferriprotoporphyrin IX hydroxide/aqua nd j%haematin is 
a polymer of haem in which the propionate side chain of the porphyrin 
of one haem molecule is complexed to the Fe(II1) of the next via a 
carbon-oxygen-iron bond. 
of haematin and p-haematin in carbonate buffer (pH 10.2), the former 
being soluble and the latter insoluble [5,9]. In the current study, unreli- 
able and non-reproducible results were obtained by this method due to 
difficulties encountered in centrifuging B-haematin and to the propen- 
sity of haem to adsorb onto submicron filters. Infrared spectroscopy 
was therefore used to characterize the reaction products [5]. This tech- 
nique unequivocally distinguishes between haematin and /?-haematin 
(see Fig. 1). The latter has sharp bands at 1660 and 1207 cm-’ which 
are absent in the former. 
Haematin was obtained by dissolving 15 mg haemin (Sigma; used as 
supplied or recrystallized from chloroform/acetic acid) in 3.0 ml of 0.1 
M NaOH. This solution was stirred in a glass titration cell connected 
to a thermostatted bath. To the solution was added 0.30 ml of I .O M 
HCI and 1.74 ml of 12.9 M acetate (pH 5) pre-incubated at 60°C. After 
0, 10 or 30 min the reaction mixture was removed from the cell, cooled 
on ice for 5 min and then filtered on an 8 pm cellulose acetate/nitrate 
Millipore filter type SC and extensively washed with water. The solid 
was dried over silica gel and phosphorus pentoxide at 37°C for 48 h. 
Infrared spectra were obtained from discs of each of the solids (2-2.5 
mg) in a CsI matrix (250 mg) on a Perkin-Elmer 983 infrared spectro- 
meter. 
The effect of drugs was studied by performing the reaction as de- 
scribed above, except that three equivalents of quinine hemi-sulphate 
(Sigma), chloroquine phosphate (Sigma), amodiaquin dihydrochloride 
(Sigma), 9-epiquinine hydrochloride (Buchler GmbH), primaquine di- 
phosphate (Sigma) or six equivalents of 8-hydroxyquinoline (Merck) 
Table 1 
The relationship between intra-erythrocytic anti-malarial activity, abil- 
ity to bind to haem, and inhibition ofb-haematin formation for various 
substances 
Substance Intra-erythro- Ability to Inhibition of 
cytic anti-ma- bind to B-haematin 
larial activity haem formation 
Chloroquine ia +* + 
Quinine +” + 
Amodiaquin +” =; + 
9-Epiquinine _b _b - 
8-Hydroxyquinoline -U ND _ 
Primaquine _g _h - 
ND, not determined, but no thick black drug-haematin clumping ob- 
served under acidic conditions and no evidence of drug in the infrared 
spectrum (Fig. 3F). 
a [16]; b [18]; ‘not reported to be anti-malarial; d[7,13];‘[7,12]; ‘[7,14,15]; 
8 [17]; h [19]. 
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was added to the reaction mixture prior to acidification, and the reac- 
tion was terminated after 30 min in each case. 
The soiubjl~ty of ha~atin in acetate solution at pH 5.0 was studied 
by adding 9.0 ~1 of 5 x 10-j M haemin dissolved in DMSO to 3.0 ml 
of each of the various acetate solutions ranging between 0.0 and 6.0 M. 
Precipitate was removed by centrifugation in an Eppendorf microcen- 
trifuge, and spectra of the soiutions were obtained on a Hewlett-Pack- 
ard 845OA diode array spectrophotometer. 
3. Results 
Formation of p-haematin from a basic (0.1 M NaOH) hae- 
matin solution acidified with glacial acetic acid to 4.5 M acetate 
concentration (final pH of about 2) and heated to 70°C has 
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Fig. 1. Infrared spectra of haematin after 0 (A), 10 (B) and 30 min (C) 
incubation in 4.5 M acetate, pH 4.5, 60°C. The definitive peaks for 
~-haematin at 1660 cm-’ and 1207 cm-’ are marked with arrows. 
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Fig. 2. Visible spectra of saturated solutions of haematin in (a) 0, (b) 
2.0, (c) 2.5, (d) 3.0, (e) 3.5, (f) 4,0, (g) 4.5, (h) 5.0, (i) 5.5 and (i) 6.0 M 
acetate, pH 5.0. Spectra were obtained at 23°C. 
been reported to proceed overnight [S]. In the current study it 
was found that the reaction was essentially complete within 30 
min at 6O”C, 2 hours at 37’C, and 8 days at 6°C. The reaction 
rate thus appears to follow the usual dependence on tempera- 
ture. Slater and Cerami [9] postulate that a haem polymerase 
enzyme is required for the reaction. They report no evidence 
of reaction in 0.5 M acetate, pH 4.8, at 37’C in the absence of 
trophozoite extract (see Fig. lb in 191). In the current study, 
however, when 5 mg of haematin was incubated at the same 
temperature in 1 1 of the identical solution, the reaction was at 
least 50% complete as judged from the infrared spectrum after 
7 days. This corresponds to a rate of approximately 380 pmol/ 
min. Even in the presence of trophozoite extracts those authors 
obtained rates of the order of 1 pmoilmin (see Fig. 3 in [9]). The 
reason for this discrepancy is not known, but may result from 
their method of assay which is based on differential solubility. 
The current study strongly suggests that the reaction is sponta- 
neous under conditions prevailing in the food vacuole. The 
reaction even proceeds in a mixture of 0.1 M glutamate and 0.4 
M glycine, pH 4.5 (complete within 91 h at 65’C, approximate 
rate of 1400 pmo~min), and in 0.1 M acetate, pH 4.2 (complete 
within 2.5 h at W’C, about 5000 pmollmin). No difference in 
the reaction rates was observed whether or not the haemin was 
recrystallized. 
Under acidic conditions haematin is essentially insoluble, but 
it was found that increasing concentrations of acetate solubilize 
an increasing proportion of the haematin (Fig. 2). This phe- 
nomenon most likely accounts in part for facilitation of the 
polymerization by acetate, as the reaction probably proceeds 
in solution. This was corroborated by the invariable observa- 
tion of a marked increase in reaction rate when the reaction 
volume was increased with the amount of haematin being kept 
constant. This is because a greater proportion of the haematin 
is in solution in the larger volume, with both solutions being 
saturated. In the food vacuole of the parasite carboxylate 
groups on free amino acids and/or peptides (derived possibly 
from haemoglobin degradation [l 11) or even a protein [9-l I] 
probably play a role analogous to the acetate, although our 
data suggest hat a specific haem polymerase nzyme is proba- 
bly not required as the reaction is chemically facile. 
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Fig. 3. As for Fig. 1 (after 30 min reaction time), except that drug was 
added to each of the haematin solutions prior to acidification. Spectra 
are for solutions containing (A) no drug, (B) three eqv of quinine, 
(C) three eqv of chloroquine, (D) three eqv of amodiaquin, (E) three 
eqv of 9epiquinine and (F) six eqv of 8-hydroxyquinoline. The posi- 
tions at which/l-haematin peaks occur are indicated with arrows. Peaks 
due to drug associated with the haematin are marked with filled circles. 
In order to ensure conveniently short reaction times, the 
effects of quinoline drugs on spontaneous p-haematin forma- 
tion were studied under the reaction conditions pH 4.5, 4.5 M 
acetate and 60°C. Under these conditions a reaction time of 30 
min is sufficient for complete reaction in the absence of drug 
(Fig. 3A). Inclusion of three equivalents of quinine (Fig. 3B), 
chloroquine (Fig. 3C) or amodiaquin (Fig. 3D) resulted in com- 
plete inhibition of p-haematin formation. In contrast, three 
equivalents of 9-epiquinine (Fig. 3E) or primaquine (result not 
shown), or six equivalents of Shydroxyquinoline (Fig. 3F) did 
not inhibit the reaction. The first three substances are known 
to bind to ferriporphyrins [7,12-151 and are intra-erythrocyti- 
tally active anti-malarial drugs [16], while primaquine is active 
only against exo-erythrocytic stages of infection [17], and 
9-epiquinine and 8-hydroxyquinoline are anti-malarially inac- 
tive [16,18]. 9-Epiquinine [18] and primaquine [ 191 have been 
shown not to bind to haem. Evidence of association of quinine, 
chloroquine or amodiaquin with haem under acidic reaction 
conditions can be seen in the infrared spectra (Fig. 3B-D, filled 
circles), while there is no evidence of similar association in the 
case of 9-epiquinine, 8-hydroxyquinoline (Fig. 3E,F) or pri- 
maquine (not shown). The characteristics of these compounds 
are summarized in Table 1. The haematin complexes of the 
intra-erythrocytically active drugs form thick black precipitates 
under the prevailing acidic conditions in the reaction vessel 
which are reminiscent of the ‘clumping’ observed in parasites 
treated with chloroquine [6]. This thick precipitate was also 
observed at room temperature. 
4. Discussion 
It has been demonstrated in the present work that spontane- 
ous formation of/?-haematin can be prevented by complexation 
of a suitable ligand to the haem molecule at low pH. Further- 
more, there is a direct relationship between intra-erythrocytic 
anti-malarial activity and inhibition of spontaneous/I-haematin 
formation among the six substances tested. As the formation 
of B-haematin does not require a catalyst, even if a polymerase 
is involved in vivo it would not seem to be the primary target 
for intra-erythrocytic anti-malarial drugs. 
These findings provide a rational explanation for the hypoth- 
esis that haem is the ‘drug receptor’ [7,8]. The main criterion 
for selection or design of intra-erythrocytic anti-malarial drugs 
is thus that they bind to haem at low pH and so block conver- 
sion of toxic haem to polymeric non-toxic /I-haematin. It is not 
yet clear whether the drugs actually enhance the toxicity of the 
haem. Clearly, the drug would also have to be able to enter the 
parasite and accumulate in the food vacuole, at least in part due 
to weak basic diprotic properties [20], and be relatively non- 
toxic to the host. 
Finally, the method presented in this work provides a power- 
ful and very simple chemical technique for screening substances 
for potential intra-erythrocytic anti-malarial activity. 
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